Trial intelligence / Profile preview

Single ketamine bolus versus ketamine bolus plus continuous infusion for analgesia in limb trauma in prehospital emergency medicine

2008-004961-25Phase 3Active

Sponsor
CHU de Lille
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ketamine in traumatic limb pain, Extremity Injuries and Acute traumatic pain (2 arms), sponsored by CHU de Lille. Primary endpoint: Morphine consumption reduction at 60 minutes. Started Oct 2008; status: active.

02

Drugs

ketamine
03

Conditions

traumatic limb painExtremity InjuriesAcute traumatic pain

Beyond the preview

Go deeper on 2008-004961-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004961-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call